A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.

NCT Number	NCT03755726
Lead Sponsor	Centre Hospitalier de PAU
Conditions	Malignant Hypertension
Enrollment	1,200 participants
Start Date	2019-09-20
Primary Completion	2034-09-20 (estimated)
Study Completion	2034-09-20 (estimated)
Updated on ClinicalTrials.gov	2026-03-23